What is Clear Labs?
Clear Labs, Inc. is a San Carlos, California-based private genomics testing company specializing in fully automated, next-generation sequencing (NGS) platforms for turnkey diagnostics. The company's technology is instrumental in areas such as SARS-CoV-2 genomic characterization and the detection of foodborne pathogens like listeria and salmonella. Founded in 2014, Clear Labs has established itself as a key innovator, receiving Emergency Use Authorization from the US FDA for its SARS-CoV-2 diagnostic test and gaining professional certification for its food safety NGS platform.
How much funding has Clear Labs raised?
Clear Labs has raised a total of $130.5M across 5 funding rounds:
Series A
$6.5M
Private Equity
$16M
Other Financing Round
$18M
Series C
$60M
Series D
$30M
Series A (2015): $6.5M with participation from Passport Capital, Khosla Ventures, and Felicis
Private Equity (2017): $16M led by Felicis Ventures, Tencent, Khosla Ventures, and Google Ventures
Other Financing Round (2020): $18M supported by Google Ventures, Redmile Group , LLC, Menlo Ventures, and Khosla Ventures
Series C (2021): $60M featuring Counterpoint Global, Menlo Ventures, Wing Ventures, T. Rowe Price Associates, and Redmile Group
Series D (2025): $30M backed by Khosla Ventures, Menlo Ventures, Felicis Ventures, and Wing Venture Capital
Key Investors in Clear Labs
Khosla Ventures
Khosla Ventures is a venture capital firm known for investing in breakthrough technologies across various sectors including AI, fintech, health, and sustainable energy. They provide strategic advice to entrepreneurs and focus on early to growth-stage companies.
Menlo Ventures
Menlo Ventures is a venture capital firm that invests in early and growth-stage technology companies, particularly in enterprise software, consumer internet, and fintech. They partner with founders through multiple stages of company scaling.
Felicis Ventures
Felicis is a venture capital firm that invests in early and growth-stage technology companies across sectors like SaaS, AI, and fintech. They are known for leading seed and Series A rounds and supporting companies through their growth phases.
What's next for Clear Labs?
The recent major strategic investment in Clear Labs positions the company for accelerated expansion and technological advancement. With a history of significant capital raises, including substantial Series B, C, and D rounds, Clear Labs is well-equipped to scale its operations, enhance its diagnostic capabilities, and broaden its market reach. The company's focus on critical areas like infectious disease characterization and food safety suggests a strategic direction towards addressing pressing public health and industry needs, likely involving further platform development and market penetration.
See full Clear Labs company page
